Hemostatic abnormalities in patients with congestive heart failure: diagnostic significance and clinical challenge

C J Davis1, P A Gurbel, W A Gattis

  • 1Sinai Center for Thrombosis Research, Sinai Hospital, Baltimore, MD 21215, USA.

Insights

Congestive heart failure (CHF) involves complex hemostatic abnormalities. This review explores platelet activation, thrombin generation, and fibrinolysis in CHF, assessing anticoagulant and antiplatelet therapy potential.

Area of Science:

  • Cardiology
  • Hematology
  • Pathophysiology

Background:

  • Congestive heart failure (CHF) remains a leading cause of morbidity and mortality.
  • Current understanding of CHF pathophysiology heavily relies on neurohormonal mechanisms.
  • Pharmacologic interventions like ACE inhibitors and beta-blockers have improved outcomes, but consensus on anticoagulants/antiplatelets is lacking.

Purpose of the Study:

  • To review current knowledge on hemostatic abnormalities in CHF patients.
  • To discuss platelet activation, thrombin generation, fibrinolysis, and endothelial dysfunction in CHF.
  • To evaluate the potential role of anticoagulants and antiplatelet agents in managing these abnormalities.

Main Methods:

  • Literature review of studies on hemostasis in congestive heart failure.
  • Analysis of research on platelet function, coagulation, and fibrinolysis in CHF.
  • Examination of clinical trial data and observational studies regarding anticoagulant/antiplatelet therapy in CHF.

Main Results:

  • CHF is associated with altered hemostasis, suggesting a prothrombotic state.
  • Mechanisms include platelet activation, increased thrombin generation, and impaired fibrinolysis.
  • Endothelial dysfunction also plays a role in the hemostatic imbalance of CHF.

Conclusions:

  • The prothrombotic state in CHF may contribute to disease pathogenesis and progression.
  • Anticoagulant and/or antiplatelet agents warrant further investigation for their potential therapeutic role.
  • Targeting hemostatic abnormalities could offer new strategies for managing congestive heart failure.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...